Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02384239
Title A Study of Palbociclib in Combination With Fulvestrant or Tamoxifen as Treatment for Metastatic Breast Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors University of California, San Francisco
Indications

breast cancer

Her2-receptor negative breast cancer

Therapies

Fulvestrant + Palbociclib

Palbociclib + Tamoxifen

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST